SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001393825-20-000005
Filing Date
2020-01-09
Accepted
2020-01-09 15:53:04
Documents
1
Group Members
JHELD@HUDSONBAYCAPITAL

Document Format Files

Seq Description Document Type Size
1 AKER_13G aker_13g.htm SC 13G 60195
  Complete submission text file 0001393825-20-000005.txt   61888
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Subject) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88005 | Film No.: 20518149
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 777 THIRD AVE., 30TH FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVE., 30TH FLOOR NEW YORK NY 10017 212-571-1244
Hudson Bay Capital Management LP (Filed by) CIK: 0001393825 (see all company filings)

IRS No.: 371511173 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G